Clincosm LogoSign in Get a demo

advanced melanoma

Showing 1 - 25 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Melanoma Trial in Belarus, Russian Federation (BCD-263, Opdivo)

Recruiting
  • Advanced Melanoma
  • Minsk, Belarus
  • +29 more
Nov 2, 2023

Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)

Not yet recruiting
  • Advanced Melanoma
  • IMC-F106C
  • +2 more
  • La Jolla, California
  • +61 more
Oct 31, 2023

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

Recruiting
  • Advanced Colorectal Carcinoma
  • +15 more
  • Fermented Wheat Germ Extract
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jul 26, 2023

Advanced Melanoma Trial in New Brunswick (Propranolol, Naltrexone)

Not yet recruiting
  • Advanced Melanoma
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jul 18, 2023

Advanced Melanoma Trial in Basel (Combination of Tumor-infiltrating lymphocyte transfer with ANV419)

Not yet recruiting
  • Advanced Melanoma
  • Combination of Tumor-infiltrating lymphocyte transfer with ANV419
  • Basel, Switzerland
    University Hospital Basel
May 19, 2023

Metastatic Melanoma, Advanced Melanoma Trial in San Francisco (XmAb22841, XmAb23104)

Not yet recruiting
  • Metastatic Melanoma
  • Advanced Melanoma
  • San Francisco, California
    University of California, San Francisco
Jan 13, 2023

Advanced Melanoma Trial in New York, Houston (LTX-315 in combination with pembrolizumab)

Recruiting
  • Advanced Melanoma
  • LTX-315 in combination with pembrolizumab
  • New York, New York
  • +7 more
Jan 23, 2023

Advanced Melanoma Trial in China (LBL-007, Toripalimab, Axitinib Tablets)

Recruiting
  • Advanced Melanoma
  • Beijing, Beijing, China
  • +7 more
Jan 9, 2023

Immune-related Adverse Event, Diarrhea, Advanced Melanoma Trial in Edmonton (Mesalamine)

Not yet recruiting
  • Immune-related Adverse Event
  • +3 more
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Dec 15, 2022

Advanced Melanoma, Tumor Infiltrating Lymphocyte, Treatment Side Effects Trial in Shanghai (Tumor Infiltrating Lymphocyte)

Recruiting
  • Advanced Melanoma
  • +3 more
  • Tumor Infiltrating Lymphocyte
  • Shanghai, China
    Shanghai Tenth People's Hospital
Dec 19, 2022

Advanced Melanoma, Metastatic Melanoma Trial in Saint Louis (Memory-like natural killer cells, Relatilmab, Nivolumab)

Not yet recruiting
  • Advanced Melanoma
  • Metastatic Melanoma
  • Memory-like natural killer cells
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 16, 2022

Advanced Head and Neck Squamous Cell Carcinoma, Advanced Breast Cancer, Advanced Melanoma Trial in Worldwide (CyPep-1,

Not yet recruiting
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +2 more
  • CyPep-1
  • Pembrolizumab 25 MG/ML [Keytruda]
  • Pittsburgh, Pennsylvania
  • +18 more
Nov 21, 2022

Response and Resistance to Pembrolizumab in Melanoma

Recruiting
  • Melanoma
  • Advanced Melanoma
  • Biopsy
  • Biospecimen Collection
  • San Francisco, California
    University of California, San Francisco
Nov 17, 2022

Advanced Melanoma Trial (Tebentafusp, Tebentafusp with Pembrolizumab, Investigators Choice)

Not yet recruiting
  • Advanced Melanoma
  • (no location specified)
Sep 19, 2022

Advanced Melanoma, Melanoma of Unknown Primary, Mucosal Melanoma Trial in United States (Ipilimumab, Nivolumab)

Active, not recruiting
  • Advanced Melanoma
  • +10 more
  • Ipilimumab
  • Nivolumab
  • Anchorage, Alaska
  • +638 more
Aug 30, 2022

Non Small Cell Lung Cancer Metastatic, Advanced Melanoma Trial in Toronto, Montréal, Québec (FMT + ICI)

Recruiting
  • Non Small Cell Lung Cancer Metastatic
  • Advanced Melanoma
  • FMT + ICI
  • Toronto, Ontario, Canada
  • +3 more
Aug 19, 2022

Advanced Melanoma Trial in Zhengzhou (Tislelizumab Injection)

Not yet recruiting
  • Advanced Melanoma
  • Tislelizumab Injection
  • Zhengzhou, Henan, China
    Department of Bone and Soft Tissue ,Henan Cancer Hospital
Aug 4, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
Aug 1, 2022

Melanoma, Advanced Melanoma, Metastatic Melanoma Trial in United States (CMP-001, Nivolumab)

Active, not recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +19 more
Aug 1, 2022

Advanced Melanoma Trial in Worldwide (lenvatinib, pembrolizumab)

Active, not recruiting
  • Advanced Melanoma
  • Chandler, Arizona
  • +22 more
Jul 21, 2022

Advanced Bladder Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston (biological,

Recruiting
  • Advanced Bladder Carcinoma
  • +34 more
  • Atezolizumab
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Advanced Melanoma in Germany Using a German Database

Completed
  • Advanced Melanoma
    • Frankfurt, Germany
      Site0001
    Jun 16, 2022

    Advanced Melanoma Trial in United States (FLX475, Ipilimumab)

    Recruiting
    • Advanced Melanoma
    • Los Angeles, California
    • +3 more
    Jun 10, 2022

    Advanced Melanoma Trial in China (HLX208)

    Recruiting
    • Advanced Melanoma
    • Peking, Beijing, China
    • +6 more
    May 1, 2022

    Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

    Recruiting
    • Advanced Differentiated Thyroid Gland Carcinoma
    • +102 more
    • Cabozantinib S-malate
    • Nivolumab
    • Chicago, Illinois
    • +2 more
    Apr 5, 2022